Methotrexate Modulates Tight Junctions Through NF‐κB, MEK, and JNK Pathways

Abstract

MTX treatment induced an increase in intestinal permeability partially related to alteration of TJs protein expression and cellular distribution that may be mediated by MAPK and NF-κB pathways. These are potential targets to limit the adverse effects of chemotherapy.